Rihards Buss, MD

Hosts Buss and Arnold go over the top highlights from EULAR 2026, including new data from studies in RA, PsA, axSpA, and PMR.

Sarah Dyball, MBBS, PhD, and Kate Harnden, MBChB, join hosts Rihards Buss, MD, to discuss their research at EULAR 2026.

Hosts Jack Arnold, MBBS, PhD, and Rihards Buss, MD, preview the sessions, themes, and abstracts they are most excited about heading into the meeting in London.

Lucy Carter, MBBS, PhD, and our hosts continue their discussion on the journey of B-cell depletion.

Lucy Carter, MBBS, PhD, joins our hosts to discuss how B-cell therapies have evolved for rheumatic disease.

Jack Arnold, MBBS, PhD, and Rihards Buss, MD, discuss early investigations of GLP-1 RAs in rheumatoid arthritis and lupus.

Jack Arnold, MBBS, PhD, and Rihards Buss, MD, discuss the growing use of GLP-1 RAs in the rheumatology field.

Rihards Buss, MD, and Jack Arnolds, MBBS, PhD, discussed the latest data on nipocalimab in lupus and deucravacitinib for PsA.

Joint Ventures is a rheumatology podcast from RheumatologyLive hosted by Jack Arnold, MBBS, PhD, and Rihards Buss, MBBS, exploring the latest news and research in the field.